Journal Article

Impact of the COVID-19 pandemic on Haemophilus influenzae infections in pediatric patients hospitalized with community acquired pneumonia

Zhou, Chanjuan, Ai, Ling, Liu, Beizhong, Gong, Fang, Fang, Liang

2024

Overview

The COVID-19 pandemic has altered the infection landscape for many pathogens. This retrospective study aimed to compare Haemophilus influenzae ( H. influenzae ) infections in pediatric CAP patients hospitalized before (2018–2019) and during (2020–2022) the COVID-19 pandemic. We analyzed the clinical epidemiology and antimicrobial resistance (AMR) patterns of H. influenzae from a tertiary hospital in southwest China. A total of 986 pediatric CAP patients with H. influenzae -associated infections were included. Compared to 2018, the positivity rate increased in 2019 but dropped significantly in 2020. Although it rose in the following 2 years, the rate in 2022 remained significantly lower than in 2019. Patients’ age during the pandemic was significantly higher than in 2018 and 2019, while gender composition remained similar across both periods. Notably, there were significant changes in co-infections with several respiratory pathogens during the pandemic. Resistance rates of H. influenzae isolates to antibiotics varied, with the highest resistance observed for ampicillin (85.9%) and the lowest for cefotaxime (0.0%). Resistance profiles to various antibiotics underwent dramatic changes during the COVID-19 pandemic. Resistance to amoxicillin-clavulanate, cefaclor, cefuroxime, trimethoprim-sulfamethoxazole, and the proportion of multi-drug resistant (MDR) isolates significantly decreased. Additionally, MDR isolates, alongside isolates resistant to specific drugs, were notably prevalent in ampicillin-resistant and β-lactamase-positive isolates. The number of pediatric CAP patients, H. influenzae infections, and isolates resistant to certain antibiotics exhibited seasonal patterns, peaking in the winter of 2018 and 2019. During the COVID-19 pandemic, sharp decreases were observed in February 2020, and there was no resurgence in December 2022. These findings indicate that the COVID-19 pandemic has significantly altered the infection spectrum of H. influenzae in pediatric CAP patients, as evidenced by shifts in positivity rate, demographic characteristics, respiratory co-infections, AMR patterns, and seasonal trends.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 631/326 / 692/699/255 / Adolescent / Amoxicillin / Ampicillin / Anti-Bacterial Agents - therapeutic use / Antibiotics / Antimicrobial resistance / Cefaclor / Cefotaxime / Cefuroxime / Child / Child, Preschool / China - epidemiology / Coinfection - drug therapy / Coinfection - epidemiology / Coinfection - microbiology / Community acquired pneumonia / Community-Acquired Infections - drug therapy / Community-Acquired Infections - epidemiology / Community-Acquired Infections - microbiology / COVID-19 / COVID-19 - complications / COVID-19 - epidemiology / Drug resistance / Drug Resistance, Bacterial / Epidemiology / Female / Haemophilus Infections - drug therapy / Haemophilus Infections - epidemiology / Haemophilus Infections - microbiology / Haemophilus influenzae / Haemophilus influenzae - drug effects / Haemophilus influenzae - isolation & purification / Hospitalization / Humanities and Social Sciences / Humans / Infant / Infections / Male / multidisciplinary / Multidrug resistance / Pandemics / Pathogens / Patients / Pediatrics / Penicillin / Respiration / Respiratory diseases / Retrospective Studies / SARS-CoV-2 - drug effects / SARS-CoV-2 - isolation & purification / Science / Science (multidisciplinary) / Seasonal variations / Sulfamethoxazole / Trimethoprim / Trimethoprim-sulfamethoxazole / β Lactamase